Moonlight Therapeutics Raises Private Funding and Secures $3M NIAID Cooperative Grant

Deal Summary

Moonlight Therapeutics raised new private funding from SOSV to support clinical development of MOON101 and received a $3,000,000 cooperative grant from the National Institute of Allergy and Infectious Diseases to fund the SURVEYOR trial and expand its pipeline.